BioCision is a leading provider of innovative tools for standardizing sample handling, cryopreservation and storage procedures. BioCision products are used worldwide by researchers in the pharmaceutical, biotechnology, academic and health care...
Portola Pharmaceuticals, Inc.
South San Francisco,
Portola Pharmaceuticals, Inc. was founded in 2003 and is headquartered in South San Francisco, CA. We completed an initial public offering in May 2013 and are traded on the Nasdaq Stock Market under the symbol PTLA. We have approximately 100...
Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company, based in Portland, Oregon, developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer. The company...
Five Prime Therapeutics, Inc.
S. San Francisco,
Job Code: #CJ3302015
Location: South San Francisco, CA Position type: Full time
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and...
BioMarin Pharmaceutical Inc.
This position will oversee planning (including scheduling and resource allocation), formatting, publishing (including QA), transmitting and archiving regulatory submissions in both paper and electronic media to health authorities in the US, EU and...
10X is looking for an outstanding individual to lead the production of consumable products. As a newly founded company, this position requires management of in-house consumable production and OEM vendors. Immediate responsibilities will be the in...
Reporting to the Associate Director of Manufacturing Operations. The primary tasks will involve the following: performing bench and kilo-lab scale polymer synthesis of novel polymers, formulating novel polymers with API, process...
Ultragenyx Pharmaceutical Inc.
Why Join Us?
Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. ...
Relypsa, Inc. is a late clinical-stage pharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product...